Table 2.

Adjusted HRs for all-cause and cardiovascular mortality

	All cause	CVD
		All CVD	IHD	CeVD
Women, n	381	153	63	33
Age at mortality, years, median (IQR)	81 (76, 86)	83 (79, 87)	83 (79, 87)	82 (77, 87)
Time to mortality*, years, median (IQR)	11 (8, 14)	11 (8, 14)	11 (7, 15)	11 (7, 14)
Adjusted HR (95% CI)†
SUA <360 µmol/L	1.00 (Reference)	1.00 (Reference)	1.00 (Reference)	1.00 (Reference)
SUA 360–419 µmol/L	1.03 (0.78 to 1.35)	0.79 (0.50 to 1.25)	1.37 (0.72 to 2.61)	0.25 (0.06 to 1.08)
SUA ≥420 µmol/L	1.32 (1.01 to 1.74)	1.31 (0.87 to 1.99)	1.96 (1.05 to 3.65)	0.82 (0.30 to 2.22)
P for trend	0.045	0.56	0.039	0.17
Men, n	506	221	138	33
Age at mortality, years, median (IQR)	80 (74, 84)	80 (76, 85)	79 (74, 84)	82 (79, 87)
Time to mortality*, years, median (IQR)	10 (6, 14)	10 (7, 14)	11 (6, 13)	10 (7, 14)
Adjusted HR (95% CI)†
SUA <360 µmol/L	1.00 (Reference)	1.00 (Reference)	1.00 (Reference)	1.00 (Reference)
SUA 360–419 µmol/L	1.11 (0.89 to 1.39)	1.18 (0.83 to 1.67)	1.23 (0.79 to 1.91)	1.53 (0.65 to 3.60)
SUA ≥420 µmol/L	1.29 (1.05 to 1.60)	1.41 (1.01 to 1.95)	1.49 (0.99 to 2.45)	1.12 (0.47 to 2.66)
P for trend	0.018	0.040	0.042	0.97

*Time from enrolment in the study to death.

†Adjusted for age, gender, education, smoking status, body mass index (BMI), hypertension and dyslipidaemia.

CeVD, cerebrovascular disease; CVD, cardiovascular disease; IHD, ischaemic heart disease; SUA, serum uric acid.